1 |
Hamashima C, Ogoshi K, Okamoto M, et al (2013). A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLOS One, 8, 79088.
DOI
|
2 |
Hamashima C (2015). Have we comprehensively evaluated the effectiveness of endoscopic screening for gastric cancer? Asian Pac J Cancer Prev, 16, 3591-2.
DOI
|
3 |
Hamilton SR, Aaltonen LA (2000). (editors). Pathology and genetics of tumours of the digestive system. the international agency for reseaech on cancer. IARC Press, Lyon.
|
4 |
Han MA, Choi KS, Lee HY, et al (2011). Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev, 12, 1657-63.
|
5 |
Han S, Kim HY, Park K, et al (1999). C-MYC expression is related with cell proliferation and associated with poor clinical outcome in human gastric cancer. J Korean Med Sci, 14, 526-30.
DOI
|
6 |
Hartgrink HH, Jansen EPM, Van Grieken NCT, et al (2009). Gastric cancer. Lancet, 374, 477-90.
DOI
|
7 |
Holian O, Wahid S, Atten MJ, et al (2002). Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide. Am J Physio Gastro Liv Physio, 282, 809-16.
|
8 |
Hundahl SA, Phillips JL, Menck HR (2000). The National Cancer Data Base report on poor survival of US gastric carcinoma patients treated with gastrectomy. Cancer, 88, 921-32.
DOI
|
9 |
Janjigian YY, Tang LH, Coit DG, et al (2011). MET expression and amplification in patients with localized gastric cancer. Cancer Epidemiol Biomarkers Prev, 20, 1021-7.
DOI
|
10 |
Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics. Ca Cancer J Clin, 61, 69-90.
DOI
|
11 |
Lai JF, Kim S, Li C, et al (2008). Clinicopathologic characteristics and prognosis for young gastric adenocarcinoma patients after curative resection. Annals Surg Oncol, 15,1464-9.
DOI
|
12 |
Lauren P (1965). The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand, 64, 31-49.
|
13 |
Lin WL, Sun JL, Chang SC, et al (2014). Factors predicting survival of patients with gastric cancer. Asian Pac J Cancer Prev, 15, 5835-8.
DOI
|
14 |
Liu X, Cai H, Huang H, et al (2011). The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients. PLOS One, 6, 29670.
DOI
|
15 |
Louis SF, Vermolen BJ, Garini Y, et al (2005). C-MYC induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proceedings Nat Acad Sci USA, 102, 9613-8.
DOI
|
16 |
Matsui A, Ihara T, Suda H, et al (2013). Gene amplification: mechanisms and involvement in cancer. Bio Mol Concepts, 4, 567-82.
|
17 |
Meyer N, Penn LZ (2008). Reflecting on 25 years with MYC. Nature Rev Cancer, 8, 976-90.
DOI
|
18 |
Movahedi M, Afsharfard A, Moradi A, et al (2009). Survival rate of gastric cancer in Iran. J Res Med Sci, 14, 367-73.
|
19 |
Oh MG, Kim JH, Han MA, et al (2014). Family history and survival of patients with gastric cancer: a meta-analysis. Asian Pac J Cancer Prev, 15, 3465-70.
DOI
|
20 |
Oliveira C, Seruca R, Carneiro F (2006). Genetics, pathology, and clinics of familial gastric cancer. Inter J Surg Path, 14, 21-33.
DOI
|
21 |
Owens SR, Appelman HD (2014). Carcinoma of the Stomach. Atlas of Esophagus and Stomach Pathology. Springer.
|
22 |
Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
DOI
|
23 |
Rhyu MG, Park WS, Jung YJ, et al (1994). Allelic deletions of MCC/APC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterol, 106, 1584-8.
|
24 |
Robertson EV, Jankowski JA (2008). Genetics of gastroesophageal cancer: paradigms, paradoxes, and prognostic utility. Am J Gastroenterol, 103, 443-9.
DOI
|
25 |
Ryan K, Birnie G (1996). Myc oncogenes: the enigmatic family. Biochem J, 314, 713-21.
|
26 |
Sadighi S, Raafat J, Mohagheghi M (2005). Gastric carcinoma: 5 year experience of a single institute. Asian Pac J Cancer Prev, 6, 195-6.
|
27 |
Sadjadi A, Zahedi M, Nouraie M, et al (2007). The first population-based cancer survey in Kerman Province of Iran. Iran J Pub Health, 36, 26-34.
|
28 |
Selcukbiricik F, Tural D, Bilici A, et al (2013). Clinicopathological features and localization of gastric cancers and their effects on survival in Turkey. Asian Pac J Cancer Prev, 14, 553-6.
DOI
|
29 |
Shah MA, Ajani JA (2010). Gastric cancer - an enigmatic and heterogeneous disease. JAMA, 303, 1753-4.
DOI
|
30 |
Shan Z, Shakoori A, Bodaghi S, et al (2013). TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo. PLOS One, 8, 66114.
DOI
|
31 |
Shon W, Sukov WR, Jenkins SM, et al (2014). MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study. Modern Path, 27, 509-15.
DOI
|
32 |
Sobin LH, Gospodarowicz MK, Wittekind C, (2011). (editors). TNM classification of malignant tumours. john wiley and sons; New York.
|
33 |
Somi MH, Farhang S, Mirinezhad SK, et al (2008). Cancer in east azerbaijan, Iran: results of a population - based cancer registry. Asian Pac J Cancer Prev, 9, 327-30.
|
34 |
Somi MH, Ghojazadeh M, Bagheri M, et al (2015). Clinicopathological factors and gastric cancer prognosis in the Iranian population: a meta-analysis. Asian Pac J Cancer Prev, 16, 853-7.
DOI
|
35 |
Suzuki S, Tenjin T, Watanabe H, et al (1997). Low level C-MYC gene amplification in gastric cancer detected by dual color fluorescence in situ hybridization analysis. J Surg Oncol, 66, 173-8.
DOI
|
36 |
Tsuboi K, Hirayoshi K, Takeuchi K, et al (1987). Expression of the C-MYC gene in human gastrointestinal malignancies. Bioch Biophy Res Commu, 146, 699-704.
DOI
|
37 |
Valentino C, Kendrick S, Johnson N, et al (2013). Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma. Am J Clin Path, 139, 242-54.
DOI
|
38 |
Vita M, Henriksson M, (2006). (editors). The myc oncoprotein as a therapeutic target for human cancer. seminars in cancer biology, elsevier.
|
39 |
Weinberg RA (2008). A biologia do cancer. artmed.
|
40 |
Wong AS, Gumbiner BM (2003). Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol, 161, 1191-203.
DOI
|
41 |
Zhang L, Hou Y, Ashktorab H, et al (2010). The impact of C-MYC gene expression on gastric cancer cell. Mol Cellu Bioch, 344, 125-35.
DOI
|
42 |
Zhou YC, Zhao HJ, Shen LZ (2015). Preoperative serum CEA and CA19-9 in gastric cancer - a single tertiary hospital study of 1,075 cases. Asian Pac J Cancer Prev, 16, 2685-91.
DOI
|
43 |
Zhu AL, Sonnenberg A (2012). Is gastric cancer again rising? J Clin Gastroenterol, 46, 804-6.
DOI
|
44 |
Adhikary S, Eilers M (2005). Transcriptional regulation and transformation by Myc proteins. Nature Rev Mol Cell Biol, 6, 635-45.
DOI
|
45 |
Almasi Z, Rafiemanesh H, Salehiniya H (2015). Epidemiology characteristics and trends of incidence and morphology of stomach cancer in Iran. Asian Pac J Cancer Prev, 16, 2757-61.
DOI
|
46 |
Altman DG (1990). Practical statistics for medical research, CRC Press.
|
47 |
Arvanitis C, Felsher DW (2005). Conditionally MYC: insights from novel transgenic models. Cancer Letters, 226, 95-9.
DOI
|
48 |
Basaran H, Koca T, Cerkesli AK, et al (2015). Treatment outcomes and survival study of gastric cancer patients: a retrospective analysis in an endemic region. Asian Pac J Cancer Prev, 16, 2055-60.
DOI
|
49 |
Bener A, Ayub H, Kakil R, et al (2008). Patterns of cancer incidence among the population of Qatar: a worldwide comparative study. Asian Pac J Cancer Prev, 9, 19-24.
|
50 |
Bizari L, Silva AE, Tajara EH (2006). Gene amplification in carcinogenesis. Genet Mol Biol, 29, 1-7.
DOI
|
51 |
Bray F, Ren JS, Masuyer E, et al (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Inter J Cancer, 132, 1133-45.
DOI
|
52 |
Brooks-Wilson A, Kaurah P, Suriano G, et al (2004). Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J med genet, 41, 508-17.
DOI
|
53 |
Calcagno DQ, Guimaraes AC, Leal MF, et al (2009). MYC insertions in diffuse-type gastric adenocarcinoma. Anticancer Res, 29, 2479-83.
|
54 |
Calcagno DQ, Leal MF, Takeno SS, et al (2005). Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma. Anticancer Res, 25, 4069-74.
|
55 |
Calcagno DQ, Leal MF, Seabra AD, et al (2006). Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma. World J Gastroenterol, 12, 6207.
DOI
|
56 |
Calcagno DQ, Leal MF, Assumpcao PP, et al (2008). MYC and gastric adenocarcinoma carcinogenesis. World J Gastroenterol, 14, 5962.
DOI
|
57 |
Calcagno DQ, Freitas VM, Leal MF, et al (2013). MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer. BMC Gastroenterol, 13, 1-10.
DOI
|
58 |
Chang MS, Uozaki H, Chong JM, et al (2006). CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Can Res, 12, 2995-3002.
DOI
|
59 |
Chen XZ, Jiang K, Hu JK, et al (2008). Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China. World J Gastroenterol, 14, 2715-22.
DOI
|
60 |
Cho BY (2014). Evaluation of the validity of current national health screening programs and plans to improve the system. Seoul University, Seoul. pp. 741-58.
|
61 |
Choi JS, Seo J, Jung EJ, et al (2012). C-MYC amplification in mucinous gastric carcinoma: a possible genetic alteration leading to deeply invasive tumors. Anticancer Res, 32, 5031-8.
|
62 |
de Souza CRT, Leal MF, Calcagno DQ, et al (2013). MYC deregulation in gastric cancer and its clinicopathological implications. PLOS One, 8, 64420.
DOI
|
63 |
Chong VH, Telisinghe PU, Abdullah MS, et al (2014). Gastric cancer in brunei darussalam: epidemiological trend over a 27 year period (1986-2012). Asian Pac J Cancer Prev, 15, 7281-5.
DOI
|
64 |
Dang CV, O'Donnell KA, Zeller KI, et al (2006). (Editors). The C-MYC target gene network. seminars in cancer biology, elsevier.
|
65 |
Derakhshan M, Yazdanbod A, Sadjadi A, et al (2004). High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. Gut, 53, 1262-6.
DOI
|
66 |
Diolaiti D, McFerrin L, Carroll PA, et al (2014). Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis. Bioch Biophy Acta, 1849, 484-500
|
67 |
Fan XM, Wong BCY, Wang WP, et al (2001). Inhibition of proteasome function induced apoptosis in gastric cancer. Inter J Cancer, 93, 481-8.
DOI
|
68 |
Fang WL, Chang SC, Lan YT, et al (2013). Molecular and survival differences between familial and sporadic gastric cancers. Biomed Res Int, 2013, 396272.
|
69 |
Ferlay J, Soeriomataram I, Ervik M, et al (2013). Cancer incidence and mortality worldwide: IARC cancerbase, lyon. international agency for research on cancer (iarc). globocan 2012. www.globocan.iarc.fr.
|
70 |
Garcia M, Jemal A, Ward EM, et al (2007). Global cancer facts and figures 2007. atlanta, GA: american cancer society.
|
71 |
Hamashima C, Shibuya D, Yamazaki H, et al (2008). The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol, 38, 259-67.
DOI
|